InsiderTrades

Beckman Daniella

SEC CIK 1513422 · EDGAR

Buying vs selling by month open-market trades, last 32 months, TNGX
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
TNGXTango Therapeutics, Inc.CFO 184.3K — $198.7K 72023-03-012026-02-03

Most active insiders at TNGX, 12 months

#InsiderTitleBoughtSold
1 TRV GP IV, LLC10% —$8.86M
2 Crystal AdamPres, R, D —$6.33M
3 Weber BarbaraDir, Executive COB —$374.4K
4 Newcomb JessicaPrincipal Accounting Off —$198.6K
5 Beckman DaniellaCFO —$126.6K
6 Ketchum John BDir ——
7 Peters MaltePres, CEO, Dir ——
8 Rothenberg MaceDir ——
9 Gall MatthewCFO ——
10 Lee SungDir ——

Transactions 7

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
D 2026-02-04 2026-02-02 TNGX Tango Therapeutics, Inc. Beckman Daniella CFO A - Grant $0.00 +44.3K 194.6K +29% $0
DM 2026-02-04 2026-02-03 TNGX Tango Therapeutics, Inc. Beckman Daniella CFO S - Sale $12.27 -10.3K 184.3K -5% -$126.6K
M 2025-02-06 2025-02-04+ TNGX Tango Therapeutics, Inc. Beckman Daniella CFO S - Sale $3.07 -8,232 154.2K -5% -$25.3K
D 2025-02-05 2025-02-03 TNGX Tango Therapeutics, Inc. Beckman Daniella CFO A - Grant $0.00 +26.1K 158.5K +20% $0
M 2024-02-08 2024-02-06+ TNGX Tango Therapeutics, Inc. Beckman Daniella CFO S - Sale $12.59 -3,725 132.4K -3% -$46.9K
D 2024-02-05 2024-02-01 TNGX Tango Therapeutics, Inc. Beckman Daniella CFO A - Grant $0.00 +39.4K 39.4K New $0
D 2023-03-02 2023-03-01 TNGX Tango Therapeutics, Inc. Beckman Daniella CFO A - Grant $0.00 +32.8K 96.7K +51% $0

Purchase Sale Sale after option exercise All abbreviations